AA-10-BH32_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, (2S)-N-[(1S)-2-[(3aR,7aS)-7-oxo-6-(2-phenylethyl)-2,3,3a,4,5,7a-hexahydropyrrolo[2,3-c]pyridin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide, Inhibitor of Apoptosis Proteins (IAP) Inhibitors;Apoptosis Inducers targeting XIAP (Novartis, 59788086)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/59788086
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the AA-10-BH32_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
PPIF peptidylprolyl isomerase F 0.386976
RPS2 ribosomal protein S2 0.385941
MT2A metallothionein 2A 0.37978
TRAF1 TNF receptor-associated factor 1 0.37978
SAA2 serum amyloid A2 0.285222
DRAP1 DR1-associated protein 1 (negative cofactor 2 alpha) 0.27497
NFKBIE nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon 0.20001

decreased expression

Symbol Name Standardized Value
TMSB4X thymosin beta 4, X-linked -0.480499
MAGED1 melanoma antigen family D1 -0.480499
CXCL14 chemokine (C-X-C motif) ligand 14 -0.480499
CRYAB crystallin, alpha B -0.467402
LAMTOR4 late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 -0.27497
TPM1 tropomyosin 1 (alpha) -0.274256
ROMO1 reactive oxygen species modulator 1 -0.264095